The KwaZulu-Natal Department of Health has announced plans to roll out the HIV prevention injection Lenacapavir at 74 clinics across the province, marking a significant step in efforts to curb new HIV infections.
The rollout follows the national launch of Lenacapavir by President Cyril Ramaphosa in Mpumalanga on Friday.
Health officials have described the injectable medication as a major breakthrough in HIV prevention. Administered just twice a year, Lenacapavir is expected to play a key role in South Africa's efforts to end AIDS as a public health threat by 2030.
KwaZulu-Natal Department of Health spokesperson Nathi Olifant said individuals wishing to receive the injection will first be required to undergo an HIV test. Eligible patients will then begin the treatment process with two oral tablets taken over a two-day period before receiving the injection.
Olifant said the department is currently finalising the list of facilities that will offer the new prevention method.
He encouraged members of the public to contact or visit their nearest clinic to determine whether Lenacapavir will be available at that facility.
According to Olifant, the department will also publish a comprehensive list of participating clinics on its official social media platforms as part of a broader communication campaign outlining the rollout process.
The rollout is expected to begin this week and forms part of ongoing efforts to expand access to innovative HIV prevention tools in a province that continues to carry one of the highest HIV burdens in the country.
Health authorities hope the introduction of Lenacapavir will improve prevention outcomes by providing a long-acting alternative to daily HIV prevention medication, making it easier for at-risk individuals to remain protected.